 Geneva, Switzerland and Boston, MA May 25 , 202 1 ObsEva SA NASDAQ: OBSV SIX: OBSN, a biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive health, today announced that its Board of Directors will propose the election at the 2021 Annual General Meeting of Shareholders to be held on May 28, 2021 of Anne VanLent as member of the Board of Directors for a term of one year expiring at the closing of the 2022 Annual General Meeting of Shareholders. 